1-2 of 2
Liliana Baila, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).

Marc PE André, MD, Oumédaly Reman, MD, Massimo Fédérico, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Théodore Girinski, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, Aspasia Stamatoullas, MD, Liliana Baila, MD, MSc, Catherine Fortpied, MSc, Michel Meignan, MD, John M. Raemaekers, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 97.
https://doi.org/10.1182/blood.V114.22.97.97
Published: 2009
Journal Articles

Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non- Hodgkin’s Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

Marinus H.J. Van Oers, MD, PhD, Martine Van Glabbeke, Liliana Baila, MD, Livia Giurgia, Richard Klasa, Robert E Marcus, Max Wolf, Eva Kimby, Anton Hagenbeek
Journal: Blood
Blood (2008) 112 (11): 836.
https://doi.org/10.1182/blood.V112.11.836.836
Published: 2008